Joseph Guarnaccia

2.3k total citations
17 papers, 1.1k citations indexed

About

Joseph Guarnaccia is a scholar working on Pathology and Forensic Medicine, Neurology and Epidemiology. According to data from OpenAlex, Joseph Guarnaccia has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 4 papers in Neurology and 4 papers in Epidemiology. Recurrent topics in Joseph Guarnaccia's work include Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (3 papers) and Stress Responses and Cortisol (2 papers). Joseph Guarnaccia is often cited by papers focused on Multiple Sclerosis Research Studies (8 papers), Peripheral Neuropathies and Disorders (3 papers) and Stress Responses and Cortisol (2 papers). Joseph Guarnaccia collaborates with scholars based in United States. Joseph Guarnaccia's co-authors include Rajita Sinha, Kenneth Rando, Keri Tuit, Beth B. Murinson, Emily B. Ansell, Norman J. Kachuck, Amy A. Pruitt, Lawrence W. Myers, Corey C. Ford and Andrew Goodman and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Clinical Infectious Diseases.

In The Last Decade

Joseph Guarnaccia

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Guarnaccia United States 12 352 301 203 190 150 17 1.1k
C. L. Cazzullo Italy 22 163 0.5× 93 0.3× 225 1.1× 86 0.5× 299 2.0× 74 1.5k
M. Haupts Germany 18 330 0.9× 145 0.5× 423 2.1× 131 0.7× 38 0.3× 44 1.2k
Kyle A. Williams United States 19 81 0.2× 271 0.9× 176 0.9× 60 0.3× 580 3.9× 44 1.5k
Simone Kern Germany 17 399 1.1× 92 0.3× 106 0.5× 32 0.2× 121 0.8× 25 1.3k
Danielle L. Chandler United States 20 389 1.1× 125 0.4× 426 2.1× 58 0.3× 28 0.2× 42 1.9k
Colin R. Bamford United States 17 217 0.6× 291 1.0× 174 0.9× 90 0.5× 124 0.8× 54 913
Bernhard Kis Germany 22 165 0.5× 1.2k 3.9× 527 2.6× 352 1.9× 235 1.6× 77 2.3k
Panu Hakola Finland 21 214 0.6× 117 0.4× 161 0.8× 365 1.9× 598 4.0× 38 2.3k
Silke Jörgens Germany 14 103 0.3× 160 0.5× 144 0.7× 66 0.3× 52 0.3× 28 790
Pingxing Xie Canada 16 81 0.2× 62 0.2× 75 0.4× 84 0.4× 345 2.3× 34 1.3k

Countries citing papers authored by Joseph Guarnaccia

Since Specialization
Citations

This map shows the geographic impact of Joseph Guarnaccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Guarnaccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Guarnaccia more than expected).

Fields of papers citing papers by Joseph Guarnaccia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Guarnaccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Guarnaccia. The network helps show where Joseph Guarnaccia may publish in the future.

Co-authorship network of co-authors of Joseph Guarnaccia

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Guarnaccia. A scholar is included among the top collaborators of Joseph Guarnaccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Guarnaccia. Joseph Guarnaccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Guarnaccia, Joseph, et al.. (2023). A pilot, randomized, placebo-controlled study of mindfulness meditation in treating insomnia in multiple sclerosis. BMC Neurology. 23(1). 263–263. 5 indexed citations
2.
Guarnaccia, Joseph, et al.. (2022). Transverse myelitis as a first event of multiple sclerosis precipitated by Pfizer-BioNTech COVID-19 vaccination. PubMed Central. 2. 100074–100074. 4 indexed citations
3.
Guarnaccia, Joseph, et al.. (2021). Patterns of Medical Cannabis Use among Patients Diagnosed with Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 50. 102830–102830. 6 indexed citations
4.
Guarnaccia, Joseph, et al.. (2021). Teriflunomide levels in women whose male sexual partner is on teriflunomide for relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders. 57. 103347–103347. 4 indexed citations
5.
Sinha, Rajita, Peihua Gu, Rachel Hart, & Joseph Guarnaccia. (2019). Food craving, cortisol and ghrelin responses in modeling highly palatable snack intake in the laboratory. Physiology & Behavior. 208. 112563–112563. 38 indexed citations
7.
Dominguez‐Villar, Margarita, Khadir Raddassi, Ann Caroline Danielsen, Joseph Guarnaccia, & David A. Hafler. (2018). Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo. Journal of Autoimmunity. 96. 40–49. 43 indexed citations
8.
Rando, Kenneth, Keri Tuit, Jonas Hannestad, Joseph Guarnaccia, & Rajita Sinha. (2012). Sex differences in decreased limbic and cortical grey matter volume in cocaine dependence: a voxel‐based morphometric study. Addiction Biology. 18(1). 147–160. 54 indexed citations
9.
Ansell, Emily B., Kenneth Rando, Keri Tuit, Joseph Guarnaccia, & Rajita Sinha. (2012). Cumulative Adversity and Smaller Gray Matter Volume in Medial Prefrontal, Anterior Cingulate, and Insula Regions. Biological Psychiatry. 72(1). 57–64. 260 indexed citations
10.
Rando, Kenneth, Kwangik Hong, Zubin Bhagwagar, et al.. (2010). Association of Frontal and Posterior Cortical Gray Matter Volume With Time to Alcohol Relapse: A Prospective Study. American Journal of Psychiatry. 168(2). 183–192. 146 indexed citations
11.
Murinson, Beth B. & Joseph Guarnaccia. (2008). Stiff-person syndrome with amphiphysin antibodies. Neurology. 71(24). 1955–1958. 119 indexed citations
12.
Guarnaccia, Joseph, et al.. (2006). Quality of life for veterans with multiple sclerosis on disease-modifying agents: Relationship to disability. The Journal of Rehabilitation Research and Development. 43(1). 35–35. 18 indexed citations
13.
Johnson, K. P., Benjamin Brooks, Corey C. Ford, et al.. (2000). Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Multiple Sclerosis Journal. 6(4). 255–266. 170 indexed citations
14.
Johnson, K. P., Benjamin Brooks, Corey C. Ford, et al.. (2000). Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Multiple Sclerosis Journal. 6(4). 255–266. 152 indexed citations
15.
Cook, S. D., Leo Wolansky, Joseph Guarnaccia, et al.. (1997). Modified total lymphoid irradiation and low dose corticosteroids in progressive multiple sclerosis. Journal of the Neurological Sciences. 152(2). 172–181. 11 indexed citations
16.
Fayad, Pierre, et al.. (1993). Painless aortic dissection presenting as a progressive myelopathy. Journal of the Neurological Sciences. 120(2). 141–144. 17 indexed citations
17.
Slater, Leonard N., et al.. (1990). Bacteremic Disease Due to Haemophilus influenzae Capsular Type f in Adults: Report of Five Cases and Review. Clinical Infectious Diseases. 12(4). 628–635. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026